[podcast src=”https://html5-player.libsyn.com/embed/episode/id/6283950/height/45/width/450/theme/standard/autonext/no/thumbnail/yes/autoplay/no/preload/no/no_addthis/no/direction/forward/” height=”45″ width=”450″ placement=”top” theme=”standard”]
Dr. Ben Sessa is a writer, psychiatrist, and researcher working in the UK to start the first ever MDMA for alcohol addiction study. We have a very exciting discussion and even get Dr. Sessa’s first reaction to the idea of DMTx. We also explore Ben’s background and his experiences with psychedelics legally – Ben is one of the few people who has ever received MDMA, LSD, DMT, ketamine, and psilocybin in a legal research setting.
We hope you enjoy this episode! Leave a comment below and let us know what you think.
Links
- Ben Sessa’s website – Mandala Therapy Limited
- BBC Three – Druglands
- Towards an Integration of Psychotherapy and Pharmacology: Using psychedelic drug-assisted psychotherapy by Dr. Ben Sessa
- Breaking Convention conference – London
- Facebook – https://www.facebook.com/BreakingConvention/
- Twitter – https://twitter.com/drsessa
Books
The Psychedelic Renaissance
To Fathom Hell or Soar Angelic
The Psychedelic Renaissance
Psychedelic Drug Treatments
Dr. Ben Sessa – Videos
https://vimeo.com/38063005
About Ben Sessa
Dr. Ben Sessa, M.B.B.S., M.D., B.Sc., M.R.C.Psych., is a consultant child and adolescent psychiatrist working in adult addiction services and with custodial detained young people in a secure adolescent setting. He trained at UCL medical school, graduating in 1997. He is interested in the developmental trajectory from child maltreatment to adult mental health disorders. Dr Sessa is currently a senior research fellow at Bristol, Cardiff and Imperial College London Universities, where he is conducting the UK’s first clinical studies with MDMA-assisted therapy for the treatment of PTSD and alcohol dependence syndrome. In the last ten years he has worked on several UK-based human pharmacology trials as study doctor or as a healthy subject administering and receiving test doses of LSD, psilocybin, MDMA, DMT, and ketamine. He is the author of several dozen peer-reviewed articles in the mainstream medical press and has written two books exploring psychedelic medicine; The Psychedelic Renaissance (2012 and 2017) and To Fathom Hell or Soar Angelic (2015). In speaking publicly at universities and medical conferences, Dr Sessa is outspoken on lobbying for change in the current system by which drugs are classified in the UK, believing a more progressive policy of regulation would reduce the harms of recreational drug use and provide increased opportunities for clinical psychedelic research. He is a co-founder and director of the UK’s Breaking Convention conference.
Enter to win a bunch of product from Bluebird Botanicals!!
Dr. Brown Specializes in whole health psychiatry. This approach differs from many other practitioners who more and more practice symptomatic management when it comes to mental health. Dr. Brown takes the perspective that the body has the ability to heal itself, but from time to time may need assistance through balancing the things that are important for physical health that are also important from mental health. These include, sleep, diet, exercise, meditative/spiritual practice and cultivating positive social relationships. Dr. Brown also has a strong command of how to balance vital nutrients in our body with the aid of supplementation to augment traditional psychopharmacological therapies. Dr. Brown’s method is aimed primarily at the treatment of Depression and Anxiety as well as other mood disorders and ADHD. Dr. Brown is a specialist in the treatment of OCD specifically and is board certified by the ABPN in both adult as well as child and adolescent psychiatry.
In addition to his work with Medicinal Mindfulness, Daniel has a successful spirituality and life coaching practice with his wife, Alison, through their company, Aspenroots Counseling LLC. Highly skilled in identifying and cultivating giftedness in young people and supporting significant life transitions, Daniel is inspired to support passionate and talented individuals striving to live into their calling. A primary focus of his practice involves assessing and addressing the benefits and difficulties related to psychedelic and cannabis use and misuse.
supportive ways, working collectively toward shared goals while enhancing the personal journey of each individual. Cosmic Sister promotes love, higher consciousness, abundance and creativity, and members pledge to hold each other’s best interests at heart as allies and affiliates. We want to see women shine.
Vilmarie Narloch, PsyD., is the Drug Education Manager at Students for Sensible Drug Policy. In this role, Vilmarie oversees the development and implementation of the SSDP Peer Education program, which is a training program for SSDP Members to become certified to deliver our drug education program, Just Say Know, to their peers. Vilmarie is passionate about reforming drug education in the U.S. and abroad, and has dedicated years of study on the topic for her dissertation. Vilmarie has taken on this position because as an organization driven by students with exceptional knowledge on drug policy and other drug use related issues, SSDP is uniquely positioned and qualified to be developing a drug education program. Additionally, Vilmarie educates staff and the network on the current state of research and treatment issues with regard to substance use disorders and mental health. Vilmarie aims to aid in the connection of policy and practice by helping our network understand the impact of policy on access to treatment and care while utilizing the latest research.
She received her Master’s of Science in Nursing from the University of Miami, Florida and post master’s certificate in psychiatry at the University of California-San Francisco. Julie maintains licenses in family medicine and psychiatry in an effort to close the gap between medical and psychiatric care, incorporating the mind/body connection for most effective treatment. She currently is in private practice in the San Francisco/Bay Area.
Peter Sjöstedt-H is an Anglo-Scandinavian philosopher who specialises in the thought of Schopenhauer, Nietzsche, and Whitehead within the fields of Philosophy of Mind and Metaphysics – especially with regard to panpsychism and altered states of sentience. Peter received a Bachelor’s degree in Philosophy and a Master’s degree in Continental Philosophy from the University of Warwick, where he was awarded a first-class distinction for his dissertation on Kant and Schelling in relation to ‘intellectual intuition’. He subsequently became a Philosophy Lecturer in London for six years but is now engaged in his PhD at Exeter University where he also teaches philosophy modules and writing skills. Peter is the author of 
Kevin graduated from Northeastern University in 2013 with a degree in neuroscience. As an undergraduate he completed an internship as a research assistant at Harvard Medical School working on the Phase 2 dose-response study investigating the therapeutic potential of MDMA-assisted psychotherapy for treatment of cancer related anxiety. Kevin was also one of the founders of the Northeastern chapter of Students for Sensible Drug Policy, and in 2009 the group hosted and co-sponsored the Boston Ibogaine Forum. He now lives in New York City where he is enrolled in a clinical psychology graduate program at The New School for Social Research and is pursuing a doctoral degree. Kevin has worked part-time for the Drug Policy Alliance, and also works as a writer covering topics related to psychedelic therapy, addiction, and mental health advocacy. His recent contributions include: New Scientist, Reason.com, Reset.me, Reality Sandwich, and VICE.com.
Thomas B. Roberts promotes the legal adaptation of psychedelics for multidisciplinary cultural uses, primarily their academic and spiritual implications. He formulated Multistate Theory (2013) coined Singlestate Fallacy, mindapps, neurosingularity, metaintelligence, and ideagen, and he named and characterized the Entheogen Reformation (2016). He is a founding member of the 
